( S ( NP-SBJ-1 ( NP ( ADJP ( RBR Less ) ( JJ robust ) ) ( NNS earnings ) ) ( PP-LOC ( IN at ) ( NP ( NP ( NNP Pfizer ) ( NNP Inc. ) ) ( CC and ) ( NP ( NNP Upjohn ) ( NNP Co. ) ) ) ) ) ( VP ( VBD were ) ( VP ( VBN attributed ) ( PP-CLR ( TO to ) ( NP ( NP ( NP ( DT those ) ( NNS companies ) ( POS ' ) ) ( JJR older ) ( NNS products ) ) ( SBAR ( WHNP-2 ( NP ( JJ many ) ) ( WHPP ( IN of ) ( WHNP ( WDT which ) ) ) ) ( S ( VP ( VBP face ) ( NP ( NP ( JJ stiffening ) ( NN competition ) ) ( PP ( IN from ) ( NP ( NP ( JJ generic ) ( NNS drugs ) ) ( CC and ) ( NP ( JJ other ) ( NNS medicines ) ) ) ) ) ) ) ) ) ) ) ) )